SLFN11 and triple-negative breast carcinoma: We first tested a cohort (N = 27) mainly composed of triple-negative breast cancer (TNBC).33,34 Figure 2a shows the frequency distribution of SLFN11 across the PDXs, indicating a non-bimodal pattern of expression.